Gene regulation of CYP4F11 in human keratinocyte HaCaT cells

Drug Metabolism and Disposition

Volumn 38, Issue 1, 2010, Pages 100-107

  Wang, Ying ^a   Bell, Jordan C ^a   Keeney, Diane S ^b   Strobel, Henry W ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; 6 [1(3,5,5,8,8 PENTAMETHYL 5,6,7,8 TETRAHYDRONAPHTHALEN 2 YL)CYCLOPROPYL] NICOTINIC ACID; ALITRETINOIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYTOCHROME P450; CYTOCHROME P450 4F11; INTERLEUKIN 1BETA; LIGAND; NICOTINIC ACID DERIVATIVE; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTHRACENES; BENZOATES; CELL LINE; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1ALPHA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KERATINOCYTES; NICOTINIC ACIDS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOIDS; SIGNAL TRANSDUCTION; TETRAHYDRONAPHTHALENES; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73149094294     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.109.029025     Document Type: Article

References (39)

1. Apriletti JW, Ribeiro RC, Wagner RL, Feng W, Webb P, Kushner PJ, West BL, Nilsson S, Scanlan TS, Fletterick RJ, and Baxter JD (1998) Molecular and structural biology of thyroid hormone receptors. Clin Exp Pharmacol Physiol Suppl 25:S2-S11.
2. Barra GB, Velasco LF, Pessanha RP, Campos AM, Moura FN, Dias SM, Polikarpov I, Ribeiro RC, Simeoni LA, and Neves FA (2004) [Molecular mechanism of thyroid hormone action]. Arq Bras Endocrinol Metabol 48:25-39.
3. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, and Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771.
4. Chedid M, Yoza BK, Brooks JW, and Mizel SB (1991) Activation of AP-1 by IL-1 and phorbol esters in T cells. Role of protein kinase A and protein phosphatases. J Immunol 147:867-873.
5. Chen JY, Penco S, Ostrowski J, Balaguer P, Pons M, Starrett JE, Reczek P, Chambon P, and Gronemeyer H (1995) RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J 14:1187-1197.
6. Desvergne B (2007) RXR: from partnership to leadership in metabolic regulations. Vitam Horm 75:1-32.
7. Elder JT, Aström A, Pettersson U, Tavakkol A, Griffiths CE, Krust A, Kastner P, Chambon P, and Voorhees JJ (1992) Differential regulation of retinoic acid receptors and binding proteins in human skin. J Invest Dermatol 98:673-679.
8. Fisher GJ, Talwar HS, Lin J, Lin P, McPhillips F, Wang Z, Li X, Wan Y, Kang S, and Voorhees JJ (1998) Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest 101:1432-1440.
9. Fisher GJ and Voorhees JJ (1996) Molecular mechanisms of retinoid actions in skin. FASEB J 10:1002-1013.
10. Green S (1995) PPAR: a mediator of peroxisome proliferator action. Mutat Res 333:101-109.
11. Hashizume T, Imaoka S, Mise M, Terauchi Y, Fujii T, Miyazaki H, Kamataki T, and Funae Y (2002) Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J Pharmacol Exp Ther 300:298-304.
12. Heinz Nau WSB (2007) Retinoids: The Biochemical and Molecular Basis of Vitamin A and Retinoid Action. Springer-Verlag, Berlin, Heidelberg, New York.
13. Hsu MH, Savas U, Griffin KJ, and Johnson EF (2007) Regulation of human cytochrome P450 4F2 expression by sterol regulatory element-binding protein and lovastatin. J Biol Chem 282:5225-5236.
14. Kalsotra A, Du L, Wang Y, Ladd PA, Kikuta Y, Duvic M, Boyd AS, Keeney DS, and Strobel HW (2008) Inflammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways. FASEB J 22:538-547.
15. Kalsotra A and Strobel HW (2006) Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism. Pharmacol Ther 112:589-611.
16. Kalsotra A, Turman CM, Kikuta Y, and Strobel HW (2004) Expression and characterization of human cytochrome P450 4F11: putative role in the metabolism of therapeutic drugs and eicosanoids. Toxicol Appl Pharmacol 199:295-304.
17. Kikuta Y, Kusunose E, and Kusunose M (2002) Prostaglandin and leukotriene omega-hydroxylases. Prostaglandins Other Lipid Mediat 68-69:345-362.
18. Kyriakis JM (1999) Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family. Gene Expr 7:217-231.
19. Laffitte BA, Kast HR, Nguyen CM, Zavacki AM, Moore DD, and Edwards PA (2000) Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J Biol Chem 275:10638- 10647.
20. Lamph WW, Wamsley P, Sassone-Corsi P, and Verma IM (1988) Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature 334:629-631.
21. Lazar MA (2005) PPAR gamma, 10 years later. Biochimie 87:9-13.
22. Leid M, Kastner P, Durand B, Krust A, Leroy P, Lyons R, Mendelsohn C, Nagpal S, Nakshatri H, and Reibel C (1993) Retinoic acid signal transduction pathways. Ann N Y Acad Sci 684:19-34.
23. Mangelsdorf DJ, Ong ES, Dyck JA, and Evans RM (1990) Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224-229.
24. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83:835-839.
25. Marikar Y, Wang Z, Duell EA, Petkovich M, Voorhees JJ, and Fisher GJ (1998) Retinoic acid receptors regulate expression of retinoic acid 4-hydroxylase that specifically inactivates all-trans retinoic acid in human keratinocyte HaCaT cells. J Invest Dermatol 111:434-439.
26. Perlmann T and Jansson L (1995) A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 9:769-782.
27. Perlmann T and Wallén-Mackenzie A (2004) Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells. Cell Tissue Res 318:45-52.
28. Qi C, Zhu Y, and Reddy JK (2000) Peroxisome proliferator-activated receptors, coactivators, and downstream targets. Cell Biochem Biophys 32:187-204.
29. Saatcioglu F, Claret FX, and Karin M (1994) Negative transcriptional regulation by nuclear receptors. Semin Cancer Biol 5:347-359.
30. Sassone-Corsi P, Ransone LJ, and Verma IM (1990) Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements. Oncogene 5:427-431.
31. Whitmarsh AJ and Davis RJ (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589-607.
32. Willy PJ and Mangelsdorf DJ (1997) Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. Genes Dev 11:289-298.
33. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, and Mangelsdorf DJ (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9:1033-1045.
34. Xiao JH, Durand B, Chambon P, and Voorhees JJ (1995) Endogenous retinoic acid receptor (RAR)-retinoid X receptor (RXR) heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. Binding of ligands to RAR only is sufficient for RAR-RXR heterodimers to confer ligand-dependent activation of hRAR beta 2/RARE (DR5). J Biol Chem 270:3001-3011.
35. Yu Y, Ge N, Xie M, Sun W, Burlingame S, Pass AK, Nuchtern JG, Zhang D, Fu S, Schneider MD, et al. (2008) Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression. J Biol Chem 283:24497-24505.
36. Zhang X, Chen L, and Hardwick JP (2000) Promoter activity and regulation of the CYP4F2 leukotriene B(4) omega-hydroxylase gene by peroxisomal proliferators and retinoic acid in HepG2 cells. Arch Biochem Biophys 378:364-376.
37. Zhang X and Hardwick JP (2000) Regulation of CYP4F2 leukotriene B4 omega-hydroxylase by retinoic acids in HepG2 cells. Biochem Biophys Res Commun 279:864-871.
38. Zhang XK and Pfahl M (1993) Hetero- and homodimeric receptors in thyroid hormone and vitamin A action. Receptor 3:183-191.
39. Zhou H, Lin A, Gu Z, Chen S, Park NH, and Chiu R (2000) 12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced c-Jun N-terminal kinase (JNK) phosphatase renders immortalized or transformed epithelial cells refractory to TPA-inducible JNK activity. J Biol Chem 275: 22868-22875.